BNSO yields 44.64% · PFE yields 6.13%● Live data
📍 BNSO pulled ahead of the other in Year 1
Combined, BNSO + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BNSO + PFE for your $10,000?
Bonso Electronics International Inc., together with its subsidiaries, designs, develops, produces, and sells electronic sensor-based and wireless products. It operates in four segments: Scales, Pet Electronic Products, Rental and Management, and Others. The Scales segment provides sensor-based scales products that include bathroom, kitchen, office, jewelry, laboratory, postal, and industrial scales for consumer, commercial, and industrial applications. The Pet Electronic Products segment develops and produces pet-related electronic products for use in consumer applications. The Rental and Management segment offers leasing of factories and machineries to third parties. The Others segment sells cordless leaf blowers, food vacuum sealers, and hydroponics growing systems, as well as scrap materials; and provides tooling and molding charges for scales. It serves private label original equipment, original brand manufacturers, and original design manufacturers primarily in the United States, Germany, and the People's Republic of China. The company also sells its pet electronic products through online platforms. The company was formerly known as Golden Virtue Limited and changed its name to Bonso Electronics International Inc. in September 1988. Bonso Electronics International Inc. was incorporated in 1988 and is based in Tsim Sha Tsui, Hong Kong.
Full BNSO Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.